Müller Helge, Schweitzer Nora, Jöhren Olaf, Dominiak Peter, Raasch Walter
Institute of Experimental and Clinical Pharmacology and Toxicology, University Clinic of Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany.
Am J Physiol Endocrinol Metab. 2007 Sep;293(3):E802-10. doi: 10.1152/ajpendo.00650.2006. Epub 2007 Jun 26.
The HPA axis is hyperactive under conditions of leptin and insulin resistance as well as after ANG II administration. We hypothesized that a hyperreactivity of the HPA axis to ANG contributes to an impaired glucose utilization in obesity, since leptin resistance and an overactive renin-angiotensin-aldosterone system are features of obesity. Zucker rats were treated with ANG via subcutaneous minipumps (0, 0.9, and 9.0 mug/h; 4 wk). PA axis reactivity and glucose homeostasis were characterized after CRH treatment and during an oral glucose tolerance test (OGTT). The elevated plasma profile of corticosterone after CRH stimulation in saline-treated OZR compared with LZR confirmed that the sensitization of the PA axis depended on leptin resistance. Irrespective of the rat strain, circulating ANG levels and blood pressure were selectively increased after administration of 9 mug/h ANG (high ANG). Only high ANG induced an elevation of the corticosterone and glucose response after CRH stimulation in OZR but did not affect the ACTH secretion. During OGTT, corticosterone and consequently glucose increased in OZR after high ANG, whereas the insulin secretion was decreased. In the adrenal glands of OZR, AT(1A) receptor mRNA levels increased after high ANG. We conclude that the impairment of glucose utilization after ANG stimulation is potentiated in leptin-resistant rats as a result of a hyperreactive PA axis, thereby confirming the functional importance of a dysregulation within the HPA axis in metabolic syndrome or obesity. The ACTH-independent stimulation of corticosterone release and the selective increase of AT(1A) receptor mRNA in the adrenals of OZR indicated a sensitization of adrenals toward ANG, causing a stimulation of the PA axis.
在瘦素和胰岛素抵抗的情况下以及给予血管紧张素II(ANG II)后,下丘脑-垂体-肾上腺(HPA)轴会过度活跃。我们假设HPA轴对ANG的反应过度会导致肥胖状态下葡萄糖利用受损,因为瘦素抵抗和肾素-血管紧张素-醛固酮系统过度活跃是肥胖的特征。通过皮下微型泵给Zucker大鼠注射ANG(0、0.9和9.0微克/小时;4周)。在促肾上腺皮质激素释放激素(CRH)处理后以及口服葡萄糖耐量试验(OGTT)期间,对HPA轴反应性和葡萄糖稳态进行了表征。与瘦素受体正常(LZR)大鼠相比,生理盐水处理的肥胖 Zucker 大鼠(OZR)在CRH刺激后皮质酮的血浆水平升高,这证实了HPA轴的敏化依赖于瘦素抵抗。无论大鼠品系如何,给予9微克/小时ANG(高ANG)后,循环ANG水平和血压均选择性升高。只有高ANG诱导OZR在CRH刺激后皮质酮和葡萄糖反应升高,但不影响促肾上腺皮质激素(ACTH)分泌。在OGTT期间,高ANG后OZR中的皮质酮进而葡萄糖升高,而胰岛素分泌减少。在OZR的肾上腺中,高ANG后血管紧张素II 1型受体(AT(1A))mRNA水平升高。我们得出结论,由于HPA轴反应过度,ANG刺激后瘦素抵抗大鼠的葡萄糖利用受损加剧,从而证实了HPA轴失调在代谢综合征或肥胖中的功能重要性。OZR肾上腺中皮质酮释放的ACTH非依赖性刺激以及AT(1A)受体mRNA的选择性增加表明肾上腺对ANG敏感,导致HPA轴受到刺激。